Cargando…
Nano-TRAIL: a promising path to cancer therapy
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand, also called apo-2 ligand (TRAIL/Apo-2L), is a cytokine that triggers apoptosis by binding to TRAIL-R1 (DR4) and TRAIL-R2 (DR5) death receptors. Apoptosis occurs through either the extrinsic or intrinsic pathway. The administration of recombina...
Autores principales: | Gampa, Siri Chandana, Garimella, Sireesha V., Pandrangi, SanthiLatha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099604/ https://www.ncbi.nlm.nih.gov/pubmed/37065863 http://dx.doi.org/10.20517/cdr.2022.82 |
Ejemplares similares
-
Mitochondria in Cancer Stem Cells: From an Innocent Bystander to a Central Player in Therapy Resistance
por: Garimella, Sireesha V, et al.
Publicado: (2023) -
A promising “TRAIL” of tanshinones for cancer
therapy
por: Ho, Tsing-Fen, et al.
Publicado: (2015) -
Role of Intracellular Iron in Switching Apoptosis to Ferroptosis to Target Therapy-Resistant Cancer Stem Cells
por: Pandrangi, Santhi Latha, et al.
Publicado: (2022) -
Polyherbal formulation conjugated to gold nanoparticles induced ferroptosis in drug-resistant breast cancer stem cells through ferritin degradation
por: Chittineedi, Prasanthi, et al.
Publicado: (2023) -
Aqueous Nyctanthes arbortristis and doxorubicin conjugated gold nanoparticles synergistically induced mTOR-dependent autophagy-mediated ferritinophagy in paclitaxel-resistant breast cancer stem cells
por: Chittineedi, Prasanthi, et al.
Publicado: (2023)